Baker Ellis Asset Management LLC Takes Position in Henry Schein, Inc. (NASDAQ:HSIC)

Baker Ellis Asset Management LLC acquired a new position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 53,741 shares of the company's stock, valued at approximately $4,069,000.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Cambridge Investment Research Advisors Inc. raised its holdings in Henry Schein by 2.4% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 5,262 shares of the company's stock valued at $459,000 after buying an additional 122 shares in the last quarter. HighTower Advisors LLC raised its holdings in Henry Schein by 18.9% during the first quarter. HighTower Advisors LLC now owns 14,030 shares of the company's stock valued at $1,220,000 after buying an additional 2,226 shares in the last quarter. MetLife Investment Management LLC raised its holdings in Henry Schein by 23.2% during the first quarter. MetLife Investment Management LLC now owns 37,733 shares of the company's stock valued at $3,290,000 after buying an additional 7,095 shares in the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its holdings in Henry Schein by 6.6% during the first quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 18,555 shares of the company's stock valued at $1,618,000 after buying an additional 1,149 shares in the last quarter. Finally, Dimensional Fund Advisors LP raised its holdings in Henry Schein by 4.1% during the first quarter. Dimensional Fund Advisors LP now owns 1,300,357 shares of the company's stock valued at $113,386,000 after buying an additional 51,106 shares in the last quarter. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

HSIC has been the topic of a number of recent analyst reports. Evercore ISI lifted their price objective on Henry Schein from $79.00 to $83.00 and gave the stock an "in-line" rating in a research note on Wednesday, February 28th. Leerink Partnrs reissued a "market perform" rating on shares of Henry Schein in a research report on Monday, February 26th. Jefferies Financial Group lifted their target price on Henry Schein from $74.00 to $81.00 and gave the stock a "hold" rating in a research report on Wednesday, March 6th. Barrington Research lifted their price objective on Henry Schein from $82.00 to $90.00 and gave the company an "outperform" rating in a report on Wednesday, February 28th. Finally, Piper Sandler lifted their price objective on Henry Schein from $78.00 to $86.00 and gave the company an "overweight" rating in a report on Monday, February 26th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus price target of $81.09.

Insider Activity

In related news, Vice Chairman James P. Breslawski sold 2,907 shares of the business's stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price of $74.37, for a total value of $216,193.59. Following the completion of the transaction, the insider now owns 209,562 shares in the company, valued at approximately $15,585,125.94. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, CEO Bradford C. Connett sold 6,430 shares of the business's stock in a transaction that occurred on Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total value of $477,620.40. Following the completion of the transaction, the chief executive officer now owns 73,108 shares in the company, valued at approximately $5,430,462.24. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Vice Chairman James P. Breslawski sold 2,907 shares of the company's stock in a transaction on Monday, March 18th. The shares were sold at an average price of $74.37, for a total transaction of $216,193.59. Following the sale, the insider now owns 209,562 shares of the company's stock, valued at approximately $15,585,125.94. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by corporate insiders.

Henry Schein Price Performance

Shares of NASDAQ:HSIC traded down $0.55 during trading on Thursday, reaching $72.89. The stock had a trading volume of 780,234 shares, compared to its average volume of 1,144,464. Henry Schein, Inc. has a 52 week low of $60.01 and a 52 week high of $85.75. The business's 50-day moving average price is $75.19 and its 200 day moving average price is $72.65. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.67 and a quick ratio of 1.00. The stock has a market capitalization of $9.37 billion, a PE ratio of 23.34, a P/E/G ratio of 1.81 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its earnings results on Tuesday, February 27th. The company reported $0.66 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.70 by ($0.04). Henry Schein had a net margin of 3.37% and a return on equity of 14.03%. The firm had revenue of $3.02 billion during the quarter, compared to the consensus estimate of $3 billion. During the same quarter last year, the firm posted $1.21 EPS. The business's revenue was down 10.5% on a year-over-year basis. As a group, equities analysts predict that Henry Schein, Inc. will post 5.07 earnings per share for the current year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.